Free Trial

YS Biopharma (YSB) SEC Filings & 10K Form

YS Biopharma logo

Recent YS Biopharma SEC Filings

DateFilerForm TypeView
11/07/2024
7:15 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:01 PM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:16 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
7:40 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
7:59 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
6:15 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
3:00 PM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
6:01 AM
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
6:45 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:30 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
3:16 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
7:32 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
04/29/2024
7:15 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:03 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:15 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:20 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
7:10 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
7:06 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:15 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:17 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
7:25 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
3:14 PM
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Zhang /MD Yi (Filed by)
Form SC 13G/A
02/14/2024
10:23 AM
Wong Fung Ching (Filed by)
YS Biopharma (Subject)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Form SC 13D
02/14/2024
6:59 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:01 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:05 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
6:10 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/25/2024
11:15 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form EFFECT
01/26/2024
5:03 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2024
3:18 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form POS AM
01/22/2024
4:10 PM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
6:10 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
11:43 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
5:37 AM
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
The centerpiece of Trump’s crypto’s masterplan … (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Click here to find out more about what could be Trump and JD Vance’s favorite coin.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:YSB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners